Skip to main content
. 2018 May 29;7:e37084. doi: 10.7554/eLife.37084

Figure 2. FBXL19 interacts with the CDK-Mediator complex in ES cells.

(A) A heatmap representing the empirically modified protein abundance index (emPAI) of identified FBXL19-interacting proteins by affinity purification mass spectrometry (AP-MS). Data shown is an average of two biological replicates. The location of the identified Mediator components within the holocomplex is summarised on the right and in (B). (B) A schematic representation of the identified FBXL19-interacting proteins. Subunits of the CDK-Mediator complex not identified by AP-MS are shown in white. (C) Western blot analysis of FS2-FBXL19 and control purifications (EV) probed with the indicated antibodies.

Figure 2—source data 1. Mass spectrometry data.
elife-37084-fig2-data1.xlsx (158.2KB, xlsx)
DOI: 10.7554/eLife.37084.006

Figure 2.

Figure 2—figure supplement 1. FBXL19 interacts with the CDK-Mediator complex in ES cells.

Figure 2—figure supplement 1.

(A) A representative silver-stained gel for FS2-FBXL19 purification and an empty vector control (EV) purification. Asterisk identifies the band corresponding to FS2-FBXL19 protein. (B) In order to visualize FBXL19 protein by western blot in Figure 2—figure supplement 1D and Figure 4B, the Fbxl19 gene was tagged by T7 knock-in in Fbxl19fl/fl ES cells using the CRISPR Cas9 system. A schematic representation of the generation of the C-terminal T7 knock-in Fbxl19 is shown. HA1/2 indicate the homology arms of the targeting construct. (C) Western blot analysis of the expression of T7-FBXL19 from nuclear extract of the generated T7 knock-in ES cell line. (D) Western blot analysis of endogenous co-immunoprecipitation (IP) of FBXL19, CDK8 and MED12 from ES cell nuclear extracts. A control IP using a non-specific antibody (α-ΗΑ) was included. (E) A schematic illustration of the different FS2-FBXL19 truncation mutants and Western blot analysis of purification of FS2-FBXL19 mutants from HEK293T cells probed with the indicated antibodies. (F) Western blot analysis of FS2-FBXL19 and control purifications (EV) probed with the indicated antibodies. (G) Western blot analysis of histone extracts generated from Fbxl19fl/fl (WT) and Fbxl19ΔCXXC (OHT) ES cells probed with two different antibodies recognizing ubiquitylated H2B K120 (H2Bub1). H4 was used as a loading control. (H) Western blot analysis of nuclear extracts from HEK293T cells transiently transfected with empty vector (EV) or Flag-FBXL19-expressing vector without (-) or following MG132 treatment (+). Blots were probed with the indicated antibodies. TBP was used as loading control.